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Key messages 
 Age at diagnosis for autism spectrum disorder varies considerably across Europe 
 Children with better language abilities, particularly females, were diagnosed later than 
non-verbal and minimally verbal children 
 Awareness initiatives and integrated detection programs should be implemented to 
lower age at diagnosis 
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Child’s verbal ability and gender are associated with age at diagnosis in a sample of young 
children with autism spectrum disorder in Europe 
 
Abstract 
Background. Autism spectrum disorder (ASD) can in some cases be reliably diagnosed by 
age 2 years, but in community settings the mean age at diagnosis is often considerably higher.   
Later diagnosis has been found to be associated with lower symptom severity, lower parental 
socioeconomic status, and fewer parental concerns. Gender differences in age at diagnosis 
have been examined, with mixed evidence.  Methods. We examined the association of child's 
verbal ability and gender, and parental education, with age at diagnosis in a large sample of 
young children with autism spectrum disorder in 18 European countries (N=1,410).  Results. 
There was considerable variation in age at diagnosis across countries.  Children with better 
communication skills were diagnosed significantly later than non-verbal and minimally 
verbal children.  There was also a significant interaction of gender with verbal ability on age 
at diagnosis, in that females with complex phrase speech were diagnosed later than males 
with the same level of verbal ability.  Conclusions. Our findings highlight the need to 
implement public awareness initiatives and training for professionals to promote early 
detection, and consequently early intervention, for autism spectrum disorder in Europe. 
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Child’s verbal ability and gender are associated with age at diagnosis in a sample of young 
children with autism spectrum disorder in Europe 
 
Introduction 
Autism spectrum disorder (ASD) can in some cases be reliably diagnosed by age 2 
years (Steiner et al. 2012), but in community settings the mean age at diagnosis is often 
considerably higher.  A recent review of 42 studies published from January 1990 through 
March 2012 found that the mean age at diagnosis ranged from 38 to 120 months (Daniels & 
Mandell 2013).  In these primarily US-based samples, later diagnosis was associated with 
lower symptom severity, lower parental socioeconomic status and fewer parental concerns.  
Some studies examined the association of age at diagnosis with gender, with mixed evidence.  
The importance of early diagnosis is its impact on families’ access to early intervention, 
advice and support. 
The aim of this study was to examine the association of child’s reported verbal ability 
and gender, and parental education with age at diagnosis in a large multi-country sample of 
European young children with ASD.  
 
Methods 
We conducted a secondary analysis of data from an online survey on the use of 
interventions for young children with ASD, developed within the Cooperation in Science and 
Technology (COST)1 Action ‘Enhancing the Scientific Study of Early Autism (ESSEA)’ 
                                                          
1 The European project Cooperation in Science and Technology (COST) is an intergovernmental framework that supports 
the coordination of nationally funded research on a European level. 
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network. The ESSEA network, composed of over 80 scientists from 23 European countries, 
was established to promote capacity in ASD research and implementation science (Bölte et 
al. 2013; García-Primo et al. 2014; McConachie et al. 2015).  The survey, which asked about 
current use of conventional intervention (such as speech and language therapy, applied 
behavioural analysis; see Salomone et. al. 2015a, in press), as well as use of medication and 
complementary and alternative medicine (see Salomone et. al. 2015b, in press), was 
distributed via parent support associations through the ESSEA network in 20 European 
countries and was open for 45 days. Two initial questions were designed to filter out 
participants who did not meet the inclusion criteria: to be a parent/caregiver of a child a) with 
ASD; and b) aged 7 or younger.  Two countries (Austria and Sweden) were excluded from 
the study as the number of participants recruited within the planned timeframe was too low 
(Austria: n = 1; Sweden: n = 5).  The final dataset included data from the following countries: 
Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Iceland, Ireland, 
Italy, the Netherlands, Norway, Poland, Portugal, Romania, Spain, the former Yugoslav 
Republic of Macedonia and the United Kingdom.  
 Ethical approval was given by the Research Ethics Committee of the Faculty of 
Children and Learning, Institute of Education, London, UK (IOE/ FPS 385).    Informed 
consent was obtained. To reduce the potential for confounding of chronological age on the 
relationship between verbal ability and age at diagnosis, a restriction strategy was 
implemented to ensure that all participants were at an age when complex phrase speech may 
potentially be present. Therefore only data from children aged >4 years were included 
(N=1,410; 81.8% male).   Information on child’s verbal ability and parental educational level 
was available for 1,245 respondents. Of these, 16% of the children were non-verbal, 27% 
used single words or simple phrases and 57% used complex phrases.  Parents’ education was 
reported as degree or postgraduate qualification in 63% of the sample. 
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Results 
The mean age at diagnosis was 42.16 months (SD=13.42); one-sample t tests were used 
to compare the mean age at diagnosis in each country with the mean of all of the remaining 
countries (N=1,410; Table 1).   
---- Table 1 about here ---- 
A three-way independent ANOVA was conducted to examine the effect of child’s 
verbal ability (non-verbal; minimally verbal; complex phrases), gender, and parental 
education (high school diploma and below; degree/post graduate) and their interactions on 
age at diagnosis (N=1,245).  There was a significant main effect of level of verbal ability on 
age at diagnosis, F (2, 1245) = 56.871, p<.001; the effect size was small (partial η2 =.08).  
The Bonferroni post hoc test revealed that the age at diagnosis was significantly higher for 
children who used complex sentences (M=47.13, SD=.65) than both non-verbal children 
(M=35.37, SD=1.18) and minimally verbal children (M=37.93, SD=.88), both ps <.001.  The 
age at diagnosis of non-verbal children and minimally verbal children were not significantly 
different from each other.  The main effect of gender on age at diagnosis was not significant, 
F (1, 1245) = .286, p=.593.  However, there was a significant interaction between verbal 
ability and gender on age at diagnosis, F (2, 1245) = 3.519, p=.030; the effect size was small 
(partial η2 =.01).  In children with complex phrase speech, age at diagnosis was higher for 
females (M=48.57, SD=1.18) than males (M=45.69, SD=.55), F (1, 1245) = 4.869, p=.028.  
The effect of gender was not significant for non-verbal (F (1, 1245) = 2.294, p=.130) or 
minimally verbal children (F (1, 1245) = .344, p=.558).  The main effect of parental 
educational level was not significant, F (1, 1245) = .199, p=.656; nor were the interactions 
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between parental educational level and verbal ability (F (1, 1245) = .965, p=.381) or gender 
(F (1, 1245) = .154, p=.695).  
---- Figure 1 about here ---- 
Fig. 1 Interaction of gender and verbal ability on age at diagnosis (N=1,245) 
 
Discussion 
We report the first data on factors associated with age at diagnosis in a large multi-
country European study.   Age at diagnosis varied considerably across countries in this 
sample.  Children in Portugal, Spain, Italy, Poland and Romania were diagnosed at a 
significantly lower age than in the rest of the countries, whereas in the Netherlands, 
Germany, Hungary, Denmark and Belgium the age at of diagnosis was significantly higher.  
This seems to reflect concerns about the difficulty of obtaining a timely ASD diagnosis, even 
in medically well-served areas of Europe (such as in Germany; Noterdaeme & Hutzelmeyer-
Nickels 2010).  However, differences across countries need to be interpreted with caution, as 
the recruitment method employed in this study (online survey advertised through parents 
associations) might have been prone to selection bias and differences in the outreach of each 
national organisation might have influenced sampling.  
Consistent with previous findings of higher age at diagnosis for less impaired children 
or children with an Asperger syndrome or a PDD-NOS diagnosis (Mazurek et al  2014; 
Mandell et al. 2010; Wiggins et al. 2006), we found that children with better verbal abilities 
tended to be diagnosed later.  We also found a significant interaction of gender with verbal 
ability on age at diagnosis, in that females with complex phrase speech were diagnosed later 
than males with the same level of verbal ability.  This finding is consistent with previous 
reports of delays in the diagnostic process for females (Russell, et al. 2011; Wiggins et al. 
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2006), and particularly for girls with better language abilities (Giarelli et al. 2010).  In our 
sample age at diagnosis did not vary by parental educational level.  Out of the 11 studies 
reviewed by Daniels & Mandell (2013) examining the association between measures of 
socioeconomic status (SES) and age at diagnosis, 6 found no association (of these, 4 studies 
used samples from the United States, one from England, one from Germany).  The reasons 
underlying these mixed findings are unclear and are likely to reflect systemic differences in 
the provision of primary diagnostic services across countries.   
These findings should be interpreted in the context of a number of limitations.  Due to 
the recruitment method, our sample cannot be considered representative of the general 
population of children with ASD.  As per inclusion criteria for the survey, all children had 
already received an ASD diagnosis and were aged <7 years, hence the reported age at 
diagnosis is likely to be lower than for the total population of individuals with ASD, some of 
whom will be identified at a later age.  Furthermore, the extent of the disadvantage for 
children with better communication abilities in receiving a timely diagnosis, particularly if 
they are female, is also likely to be underestimated.  Public awareness initiatives as well as 
training for professionals should be put in place to promote early detection of ASD and 
access to intervention across Europe (Oosterling et al. 2010).   
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Figure 1 Interaction of gender and verbal ability on age at diagnosis (N=1,245) 
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 Table 1 Age at diagnosis by country: comparisons of mean age in each country with mean 
age in all of the remaining countries 
 
 
  N   M (SD)   t (df) p effect size* 
Portugal 113 
 
33.53 (11.66) -8.550 (112) <.001 0.63 
Italy 88 
 
35.73 (13.02) -4.944 (87) <.001 0.47 
Spain 186 
 
36.66 (13.54) -6.375 (185) <.001 0.42 
Romania 44 
 
37.55 (11.23) -2.813 (43) .007 0.39 
Poland 60 
 
37.85 (11.7) -2.980 (59) .004 0.36 
Macedonia 22 
 
39.59 (10.53) -1.162 (21) .258  
Czech Republic 81 
 
42.21 (10.26) .044 (80) .965  
Norway 24 
 
42.5 (14.37) .119 (23) .906  
Iceland 46 
 
42.59 (10.9) .278 (45) .782  
France 154 
 
42.76 (12.75) .662 (153) .509  
United Kingdom 92 
 
43.28 (12.42) .929 (91) .355  
Finland 41 
 
44 (11.55) 1.053 (40) .299  
Belgium 96 
 
45.71 (13.33) 2.800 (95) .006 0.28 
Ireland 22 
 
46.59 (13.45) 1.570 (21) .131  
Hungary 106 
 
47.88 (12.37) 5.150 (105) <.001 0.45 
Germany 79 
 
48.44 (10.98) 5.387 (78) <.001 0.52 
Netherlands 90 
 
50.02 (12.22) 6.524 (89) <.001 0.57 
Denmark 66   50.17 (14.4) 4.741 (65) <.001 0.51 
Total 1,410   42.16 (13.42)   
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